13F Filings History of NVIDIA CORP

13F snapshot Latest parsed holdings, value, and filing-period context. 1 signal
Form 13F summary
  • NVIDIA CORP Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • NVIDIA CORP reported 5 equity holdings with a total reported market value of $13,104,819,528 for Q4 2025. Top reported holdings included INTEL CORP, SYNOPSYS INC, COREWEAVE INC, NOKIA CORP, and NEBIUS GROUP N.V..
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Rebecca Peters - VP, Deputy General Counsel and Assistant Secretary
Manager location
Santa Clara, CA

Follow Filing Activity

Follow NVIDIA CORP with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q4 2025
Latest value
$13,104,819,528
Quarter delta
+$9,261,138,189
Accepted
17 Feb 2026, 16:27
Rows shown
1-2 of 2
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q4 2025 5 $13,104,819,528 +$11,266,653,731 -$387,640,733 +$10,879,012,998 INTEL CORP, SYNOPSYS INC, COREWEAVE INC, NOKIA CORP, NEBIUS GROUP N.V. 13F-HR 17 Feb 2026, 16:27
Q3 2025 6 $3,843,681,339 $0 $0 $0 COREWEAVE INC, APPLIED DIGITAL CORP, ARM HOLDINGS PLC, NEBIUS GROUP N.V., RECURSION PHARMACEUTICALS IN 13F-HR 14 Nov 2025, 17:05
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .